Search

Xiang Li Phones & Addresses

  • Clarksville, MD
  • Columbia, MD
  • 9625 Pastora Pl, Columbia, MD 21045

Work

Company: Lehigh university Apr 2010 Position: Graduate research assistant

Education

School / High School: Lehigh University- Bethlehem, PA Jan 2009 Specialities: Master of Science in Civil Engineering

Skills

Scientific Software: ADINA • Auto CAD • MATHCAD • ABAQUS • ANSYS • MATLAB • SAP2000 • ETABS • STAAD PRO. Program Languages: PATRAN • Visual Basic • SQL Server • Access • Excel • PowerPoint • 3Dmax • Photoshop • Adobe Premier

Ranks

Licence: New York - Currently registered Date: 2013

Emails

l***4@yahoo.com

Professional Records

Lawyers & Attorneys

Xiang Li Photo 1

Xiang Li - Lawyer

View page
Licenses:
New York - Currently registered 2013
Education:
Southern Methodist University, Dedman School of Law

Medicine Doctors

Xiang Li Photo 2

Xiang Li

View page
Specialties:
Internal Medicine
Work:
Li & Li Mds
98 James St STE 201, Edison, NJ 08820
(732) 906-9882 (phone), (732) 906-9893 (fax)
Education:
Medical School
Jinan Univ, Med Coll, Guangzhou City, Guangdong, China
Graduated: 1984
Procedures:
Arthrocentesis
Electrocardiogram (EKG or ECG)
Pulmonary Function Tests
Vaccine Administration
Conditions:
Abnormal Vaginal Bleeding
Acne
Acute Bronchitis
Acute Conjunctivitis
Acute Pharyngitis
Languages:
Chinese
English
Description:
Dr. Li graduated from the Jinan Univ, Med Coll, Guangzhou City, Guangdong, China in 1984. He works in Edison, NJ and specializes in Internal Medicine. Dr. Li is affiliated with John F Kennedy Medical Center - Johnson Rehabilitation Center.
Xiang Li Photo 3

Xiang Li

View page
Specialties:
Internal Medicine
General Practice
Education:
Medical College Of Jinan University (1984)

Resumes

Resumes

Xiang Li Photo 4

Xiang Li Bethlehem, PA

View page
Work:
Lehigh University

Apr 2010 to 2000
Graduate Research Assistant

Shijingshan Construction Company

May 2010 to Aug 2010
Intern

KCI TECHNOLOGIES, INC
Sparks, MD
Jan 2010 to Feb 2010
Intern

State Key Laboratory for Disaster Reduction in Civil Engineering on The Shaking Table Testing Division of Tongji University (TJST)

Sep 2007 to May 2009
Undergraduate Research Assistant

Education:
Lehigh University
Bethlehem, PA
Jan 2009 to Jan 2011
Master of Science in Civil Engineering

Tongji University
Jan 2005 to Jan 2009
BS in Civil Engineering

Skills:
Scientific Software: ADINA, Auto CAD, MATHCAD, ABAQUS, ANSYS, MATLAB, SAP2000, ETABS, STAAD PRO. Program Languages: PATRAN, Visual Basic, SQL Server, Access, Excel, PowerPoint, 3Dmax, Photoshop, Adobe Premier

Business Records

Name / Title
Company / Classification
Phones & Addresses
Xiang Y. Li
President
Brac International, Inc
Amusement/Recreation Services
4 Narrowleaf Ct, Gaithersburg, MD 20878
(202) 390-8283
Xiang Li
President, Director
MILES ROCK ENTERPRISES, INC
Reston, VA 20195
PO Box 2579, Herndon, VA 20195
343 Almeria Ave, Miami, FL 33134

Publications

Us Patents

Devices And Methods For Profiling Enzyme Substrates

View page
US Patent:
7368258, May 6, 2008
Filed:
Jun 6, 2006
Appl. No.:
11/447089
Inventors:
Charles Bieberich - Brookville MD, US
Xiang Li - Baltimore MD, US
Assignee:
University of Maryland, Baltimore County - Baltimore MD
International Classification:
C12Q 1/50
US Classification:
435 17
Abstract:
The present invention relates to apparatus and methods for separating and detecting enzyme substrates using separation gels. For example, the apparatus and methods can be used to separate and detect kinase substrates for further analysis. The apparatus and methods can also be used to detect enzyme inhibitors, such as kinase inhibitors.

Devices And Methods For Profiling Enzyme Substrates

View page
US Patent:
7666617, Feb 23, 2010
Filed:
Mar 27, 2008
Appl. No.:
12/078157
Inventors:
Charles Bieberich - Brookeville MD, US
Xiang Li - Baltimore MD, US
Assignee:
University of Maryland, Baltimore County - Baltimore MD
International Classification:
C12Q 1/50
US Classification:
435 17
Abstract:
The present invention relates to apparatus and methods for separating and detecting enzyme substrates using separation gels. For example, the apparatus and methods can be used to separate and detect kinase substrates for further analysis. The apparatus and methods can also be used to detect enzyme inhibitors, such as kinase inhibitors.

Pim Kinase Inhibitors In Combination With Autophagy Inhibitors For Treatment Of Cancers

View page
US Patent:
20200230125, Jul 23, 2020
Filed:
Oct 3, 2018
Appl. No.:
16/753006
Inventors:
- Baltimore MD, US
XIANG LI - BALTIMORE MD, US
International Classification:
A61K 31/4706
A61K 31/365
A61K 31/409
A61K 31/426
A61K 31/454
A61K 31/5025
A61K 31/551
Abstract:
The present invention provides for a method of treating cancer and/or reducing proliferation of cancer cells, the method comprising administering to a subject in need of such treatment a composition comprising a PIM kinase inhibitor that exhibits changes in expressed RNA or ribosomal binding proteins in combination with a compound that inhibits autophagy.

Pim Kinase Inhibitors In Combination With Rna Splicing Modulators/Inhibitors For Treatment Of Cancers

View page
US Patent:
20200046689, Feb 13, 2020
Filed:
Oct 10, 2019
Appl. No.:
16/598536
Inventors:
- Baltimore MD, US
XIANG LI - BALTIMORE MD, US
TEJASHREE JOGLEKAR - SAVAGE MD, US
International Classification:
A61K 31/454
A61K 45/06
A61K 31/365
A61P 35/00
G01N 33/50
A61K 31/437
A61K 31/453
A61K 31/351
A61K 31/506
A61K 31/4412
A61K 31/426
A61K 31/165
A61K 31/551
A61K 31/5025
Abstract:
The present invention provides for a method of treating cancer and/or reducing proliferation of cancer cells, the method comprising administering to a subject in need of such treatment a composition comprising a PIM kinase inhibitor that exhibits changes of mRNA splicing in combination with a compound that modulates/inhibits activity of an RNA splicing factor protein. Further, changes in splicing of mRNAs and phosphorylation of RNA splicing factors can be used as biomarkers for patient responsiveness to anti-PIM treatment and also suggest effective combinatorial therapies, including synergistic combination.

Pim Kinase Inhibitors In Combination With Rna Splicing Modulators/Inhibitors For Treatment Of Cancers

View page
US Patent:
20190076416, Mar 14, 2019
Filed:
Mar 22, 2017
Appl. No.:
16/082325
Inventors:
- BALTIMORE MD, US
XIANG LI - BALTIMORE MD, US
TEJASHREE JOGLEKAR - SAVAGE MD, US
International Classification:
A61K 31/454
A61K 31/365
A61K 45/06
A61P 35/00
G01N 33/50
Abstract:
The present invention provides for a method of treating cancer and/or reducing proliferation of cancer cells, the method comprising administering to a subject in need of such treatment a composition comprising a PIM kinase inhibitor that exhibits changes of mRNA splicing in combination with a compound that modulates/inhibits activity of an RNA splicing factor protein. Further, changes in splicing of mRNAs and phosphorylation of RNA splicing factors can be used as biomarkers for patient responsiveness to anti-PIM treatment and also suggest effective combinatorial therapies, including synergistic combination.

Isbn (Books And Publications)

Computer Simulation of Earthquake Effects: Proceedings of Sessions of Geo-Denver 2000

View page
Author

Xiang Song Li

ISBN #

0784405239

Wen Zi You Xi Qu Tan: Wenziyouxiqutan

View page
Author

Xiang Li

ISBN #

7503303107

Xiang Li from Clarksville, MD Get Report